Inovio Pharmaceuticals, Inc. Loss Submission Form

Inovio Pharmaceuticals, Inc. The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between February 14, 2020 and March 9, 2020.

Inovio Pharmaceuticals, Inc.

According to the Inovio lawsuit, throughout the Class Period, defendants made misleading statements about the company’s development of a purported vaccine for the novel coronavirus, artificially inflating the company’s share price and resulting in significant investor losses.

“Inovio Pharmaceuticals, Inc.”

If you suffered a loss in Inovio you have until May 12, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

To receive more information, please fill out the form.

Submit Your Information

This submission does not create an attorney-client relationship. By submitting your information, you are giving us your express consent to contact you by email, text message, SMS, or call you by telephone.

Privacy Policy